Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$6,125,924
+$643,654 QoQ
Shares Held
24,344
-3.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.45%
of 13F equity value
Holder Rank
#1,189
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cornell Pochily Investment Advisors, Inc. holds $19,372,779 across 8 Drug Manufacturers - General names. ABBV ranks #1 (31.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
24,344 | $6,125,924 | |
| 2 | JNJ |
Johnson & Johnson
|
18,975 | $4,819,080 | |
| 3 | AMGN |
Amgen Inc
|
7,009 | $2,538,099 | |
| 4 | LLY |
ELI LILLY & Co
|
1,708 | $2,048,626 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
10,724 | $1,354,870 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,019 | $1,030,441 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
13,451 | $775,046 | |
| 8 | PFE |
Pfizer Inc
|
28,268 | $680,693 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,125,924 | 24,344 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $5,482,270 | 25,207 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $6,062,068 | 26,531 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $6,036,710 | 26,072 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $4,985,010 | 26,856 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $5,639,649 | 26,917 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $4,795,945 | 26,989 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $5,392,191 | 27,305 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $4,708,567 | 27,452 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $4,692,534 | 25,769 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $3,994,971 | 25,779 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $7,088,697 | 47,556 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $6,402,773 | 47,523 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $7,583,621 | 47,585 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $7,746,613 | 47,934 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $6,456,843 | 48,110 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $7,374,041 | 48,146 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $7,878,870 | 48,602 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $6,739,128 | 49,772 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $5,362,864 | 49,716 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $5,596,631 | 49,686 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $5,377,127 | 49,687 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $6,642,228 | 61,990 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $5,467,980 | 62,427 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $6,171,202 | 62,856 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $4,766,065 | 62,555 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||